Key Events This Week
1 June: New 52-week and all-time high at Rs.1,588.40
3 June: Intraday low amid heavy price pressure at Rs.1,360
5 June: Week closes at Rs.1,388.90, down 10.71%

Novartis India Ltd is Rated Hold
2026-06-14 10:10:41Novartis India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Novartis India Ltd Hits Intraday Low Amid Price Pressure on 3 June 2026
2026-06-03 10:31:25Novartis India Ltd experienced a notable decline today, touching an intraday low of Rs 1360, reflecting a sharp price correction amid broader market weakness and sector underperformance. The stock’s downward trajectory was marked by a 7.16% fall from its previous close, underscoring immediate selling pressure and cautious sentiment among market participants.
Read full news article
Novartis India Ltd is Rated Hold
2026-06-03 10:11:38Novartis India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and market standing.
Read full news article
Broad-Based Technical Strength Lifts Novartis India Ltd to 52-Week High of Rs 1588.4
2026-06-01 09:48:07Surging to a new 52-week high of Rs 1588.4 on 1 Jun 2026, Novartis India Ltd has demonstrated remarkable price momentum, outperforming the Sensex by a wide margin over the past year. This milestone caps a 47.29% rally from its 52-week low of Rs 750, underscoring a sustained uptrend fuelled by strong technical signals across multiple timeframes.
Read full news articleNovartis India Ltd Gains 14.16%: 8 Key Factors Driving the Surge
2026-05-31 09:00:07
Key Events This Week
25 May: New 52-week high at Rs.1,424.9 and all-time high near Rs.1,422.25
26 May: New 52-week high at Rs.1,430 and all-time high at Rs.1,425.00
27 May: New 52-week high at Rs.1,462.5 and all-time high at Rs.1,458
29 May: New 52-week and all-time high at Rs.1,496.85 and Rs.1,497.35

From Steady Gains to Record Close: Novartis India Ltd Hits All-Time High at Rs 1,497.35
2026-05-29 10:06:20Extending its remarkable rally, Novartis India Ltd touched a fresh all-time high of Rs 1,497.35 on 29 May 2026, marking a significant milestone in its multi-year ascent that has outpaced the broader market by a wide margin.
Read full news article
Broad-Based Technical Strength Lifts Novartis India Ltd to 52-Week High of Rs 1496.85
2026-05-29 09:44:54With a decisive break above Rs 1496.85 on 29 Jun 2026, Novartis India Ltd has reached a fresh 52-week high, extending its impressive 39.98% return over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained gains over the last three trading sessions, signalling robust price action in the pharmaceuticals sector.
Read full news articleUpdates on Open Offer
12-Jun-2026 | Source : BSEAxis Capital Ltd (Manager to the Open Offer) has informed BSE regarding Open offer for acquisition of up to 6419608 (sixty four lakhs nineteen thousand six hundred and eight) fully paid-up equity shares of face value of INR 5 each (Equity Shares) from the Public Shareholders of Novartis India Ltd (Target Company) representing 26% of the Voting Share Capital of the Target Company by WaveRise Investments Limited (Acquirer 1) ChrysCapital Fund X the first scheme of ChrysCapital Trust I a category II alternative investment fund registered with the Securities and Exchange Board of India (Acquirer 2) and Two Infinity Partners (Acquirer 3) (Acquirer 1 Acquirer 2 and Acquirer 3 collectively referred to as the Acquirers) along with ChrysCapital X LLC (PAC 1) and OceanEdge Investments Limited (PAC 2) (PAC 1 and PAC 2 collectively referred to as the PACs) in their capacity as persons acting in concert with the Acquirers (Open Offer).
Pre-Offer Advertisement & Corrigendum to Detailed Public Statement
11-Jun-2026 | Source : BSEAxis Capital Ltd (Manager to the Open Offer) has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended and corrigendum to the detailed Public Statement for the attention of the Public Shareholders of Novartis India Ltd (Target Company).
Updates on Open Offer
11-Jun-2026 | Source : BSEAxis Capital Ltd (Manager to the Open Offer) has informed BSE regarding the updates on Open offer for acquisition of up to 6419608 (sixty four lakhs nineteen thousand six hundred and eight) fully paid-up equity shares of face value of INR 5 each (Equity Shares) from the Public Shareholders of Novartis India Ltd (Target Company) representing 26% of the Voting Share Capital of the Target Company by WaveRise Investments Ltd (Acquirer 1) ChrysCapital Fund X the first scheme of ChrysCapital Trust I a category II alternative investment fund registered with the Securities and Exchange Board of India (Acquirer 2) and Two Infinity Partners (Acquirer 3) (Acquirer 1 Acquirer 2 and Acquirer 3 collectively referred to as the Acquirers) along with ChrysCapital X LLC (PAC 1) and OceanEdge Investments Ltd (PAC 2) (PAC 1 and PAC 2 collectively referred to as the PACs) in their capacity as persons acting in concert with the Acquirers (Open Offer).
Corporate Actions
No Upcoming Board Meetings
Novartis India Ltd has declared 500% dividend, ex-date: 23 Jul 25
No Splits history available
No Bonus history available
No Rights history available







